Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 1
1980 2
1981 3
1982 5
1983 2
1984 3
1985 2
1986 2
1987 2
1988 2
1989 3
1990 4
1991 5
1992 1
1993 1
1994 1
1995 2
1996 2
1998 4
1999 3
2000 5
2001 3
2002 1
2003 3
2004 4
2005 1
2006 2
2007 5
2008 1
2009 6
2010 1
2011 1
2012 3
2013 5
2014 5
2015 3
2016 5
2017 5
2018 1
2019 2
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

111 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain.
Kostich W, Hamman BD, Li YW, Naidu S, Dandapani K, Feng J, Easton A, Bourin C, Baker K, Allen J, Savelieva K, Louis JV, Dokania M, Elavazhagan S, Vattikundala P, Sharma V, Das ML, Shankar G, Kumar A, Holenarsipur VK, Gulianello M, Molski T, Brown JM, Lewis M, Huang Y, Lu Y, Pieschl R, O'Malley K, Lippy J, Nouraldeen A, Lanthorn TH, Ye G, Wilson A, Balakrishnan A, Denton R, Grace JE, Lentz KA, Santone KS, Bi Y, Main A, Swaffield J, Carson K, Mandlekar S, Vikramadithyan RK, Nara SJ, Dzierba C, Bronson J, Macor JE, Zaczek R, Westphal R, Kiss L, Bristow L, Conway CM, Zambrowicz B, Albright CF. Kostich W, et al. Among authors: zaczek r. J Pharmacol Exp Ther. 2016 Sep;358(3):371-86. doi: 10.1124/jpet.116.235333. Epub 2016 Jul 13. J Pharmacol Exp Ther. 2016. PMID: 27411717 Free PMC article.
Optimal ECG Lead System for Exercise Assessment of Ischemic Heart Disease.
Kania M, Maniewski R, Zaczek R, Kobylecka M, Zavala-Fernandez H, Królicki L, Opolski G. Kania M, et al. Among authors: zaczek r. J Cardiovasc Transl Res. 2020 Oct;13(5):758-768. doi: 10.1007/s12265-019-09949-3. Epub 2019 Dec 23. J Cardiovasc Transl Res. 2020. PMID: 31872329
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists.
Hill MD, Fang H, King HD, Iwuagwu CI, McDonald IM, Cook J, Zusi FC, Mate RA, Knox RJ, Post-Munson D, Easton A, Miller R, Lentz K, Clarke W, Benitex Y, Lodge N, Zaczek R, Denton R, Morgan D, Bristow L, Macor JE, Olson R. Hill MD, et al. Among authors: zaczek r. ACS Med Chem Lett. 2016 Dec 1;8(1):133-137. doi: 10.1021/acsmedchemlett.6b00471. eCollection 2017 Jan 12. ACS Med Chem Lett. 2016. PMID: 28105289 Free PMC article.
A Glutamate N-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical Use.
Myers SJ, Ruppa KP, Wilson LJ, Tahirovic YA, Lyuboslavsky P, Menaldino DS, Dentmon ZW, Koszalka GW, Zaczek R, Dingledine RJ, Traynelis SF, Liotta DC. Myers SJ, et al. Among authors: zaczek r. J Pharmacol Exp Ther. 2021 Oct;379(1):41-52. doi: 10.1124/jpet.120.000370. Epub 2021 Sep 7. J Pharmacol Exp Ther. 2021. PMID: 34493631
The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists.
Li YW, Fitzgerald L, Wong H, Lelas S, Zhang G, Lindner MD, Wallace T, McElroy J, Lodge NJ, Gilligan P, Zaczek R. Li YW, et al. Among authors: zaczek r. CNS Drug Rev. 2005 Spring;11(1):21-52. doi: 10.1111/j.1527-3458.2005.tb00034.x. CNS Drug Rev. 2005. PMID: 15867951 Free PMC article. Review.
111 results